Psychedelics like psilocybin, MDMA and LSD are being tested as psychiatric treatments. Clinical trials suggest these drugs may alleviate mood disorders, such as treatment-resistant depression and bipolar disorder; anxiety disorders like post-traumatic stress disorder (PTSD); eating disorders like anorexia; and addiction, including alcohol use disorder.
In those trials, psychedelics are paired with psychotherapy, with the idea that the trip-inducing drugs may enhance therapy's effects. But the psychotherapy element is barely described in most of the studies, experts say.
